.png)
Oxitone Medical
World-first FDA-cleared wrist pulse-oximeter with AI continuous-monitoring analytics
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
Oxitone Medical appears positioned as a niche remote patient monitoring company focused on wrist-worn continuous vitals capture, with emphasis on chronic-care use cases and FDA-cleared messaging. The public footprint suggests a technically credible product company, but commercial scale and market traction signals remain limited.
Efficiency Ratio
The company shows meaningful innovation output relative to its small apparent team size, but public evidence of broad revenue conversion or organizational scale is modest.
Evidence Signals
Website states it is introducing the Oxitone 2000M, a next-generation wrist-worn monitor for continuous blood pressure and vitals.
Company announced mass-production of new-generation devices, indicating a move from development toward manufacturing scale-up.
Ascom lists Oxitone in its interoperability ecosystem, suggesting integration/partner ecosystem activity.
LinkedIn describes Oxitone as a wearables and digital health company serving providers with continuous remote care for chronic and complex conditions.
PitchBook profile indicates the company was founded in 2010, has about 11 employees, and has raised $1.9M.
F6S describes Oxitone as an FDA-cleared personalized preventive care solution for complex diseases.
The company maintains a careers page with anti-phishing guidance, but no clear public hiring volume is visible in the provided results.
- About
- Israeli wearables/digital-health company (HQ Kfar Saba, Israel; originated in the Israel Innovation Authority's Ashkelon incubator), founded in 2010 by Dr. Leon Eisen (PhD physics, Weizmann). Its Oxitone 1000M is the world's first FDA-cleared wrist pulse-oximetry medical monitor that works without a fingertip probe — patented 'FlexSense' biosensors embrace the wrist's ulnar bone to read SpO2, pulse, HRV, skin temperature and motion every second, with the VitalsTone AI engine deriving hypoxia, apnea, activity, sleep and physiological-stress indices and flagging deterioration. Targeted at continuous remote care for severe chronic/complex patients; integrated by Ascom for hospital COVID monitoring. The passive continuous-vitals + deterioration-alerting model maps to the casualty-monitoring / prolonged-field-care thread of C12. Defense relevance is commercial-first.
- Tags
- #wearable #pulseoximetry #spo2 #wrist #rpm #vitals #ai #fda #chroniccare